Danicamtiv, a novel oral selective cardiac myosin activator, demonstrated promising beneficial effects on left ventricular systolic function coupled with marked improvements in left atrial volume and ...

Sacubitril/valsartan (Entresto) appears to improve measures of cardiac structure and function compared with valsartan alone in asymptomatic preclinical heart failure with preserved ejection fraction, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In patients with HF with preserved ejection fraction, ...

Please provide your email address to receive an email when new articles are posted on . “Dyspnea due to left atrial pressure overload during exercise is a hallmark of heart failure with preserved or ...

At present, there are no approved therapies for pre–heart failure with preserved ejection fraction (pre-HFpEF); instead, cardiovascular risk factor management is often utilized in this patient ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

"Atrial fibrillation and heart failure are growing epidemics, and both beget each other." ---- Jonathan Hsu, MD, MAS, University of California San Diego “Atrial fibrillation and heart failure are ...

The efficacy of catheter ablation for heart failure (HF) patients with atrial fibrillation (Afib or AF) hinged on the phenotype of disease, researchers reported based on a meta-analysis. Compared with ...